{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:02:07Z","timestamp":1790499727406,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T00:00:00Z","timestamp":1329436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11882-012-0250-y","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T06:49:12Z","timestamp":1329374952000},"page":"163-174","source":"Crossref","is-referenced-by-count":68,"title":["Pathogenesis and Management of Nasal Polyposis in Cystic Fibrosis"],"prefix":"10.1007","volume":"12","author":[{"given":"Jochen G.","family":"Mainz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assen","family":"Koitschev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,17]]},"reference":[{"key":"250_CR1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066\u201373.","journal-title":"Science"},{"key":"250_CR2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","volume":"245","author":"B Kerem","year":"1989","unstructured":"Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073\u201380.","journal-title":"Science"},{"key":"250_CR3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/028418501127347214","volume":"42","author":"HB Eggesbo","year":"2001","unstructured":"Eggesbo HB, Sovik S, Dolvik S, Eiklid K, Kolmannskog F. CT characterization of developmental variations of the paranasal sinuses in cystic fibrosis. Acta Radiol. 2001;42:482\u201393.","journal-title":"Acta Radiol"},{"key":"250_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02914539","volume":"9","author":"VV King","year":"1991","unstructured":"King VV. Upper respiratory disease, sinusitis, and polyposis. Clin Rev Allergy. 1991;9:143\u201357.","journal-title":"Clin Rev Allergy"},{"key":"250_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00106-005-1328-9","volume":"54","author":"A Koitschev","year":"2006","unstructured":"Koitschev A, Wolff A, Koitschev C, Preyer S, Ziebach R, Stern M. Routine otorhinolaryngological examination in patients with cystic fibrosis. HNO. 2006;54:361\u20134. 366, 368.","journal-title":"HNO"},{"key":"250_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.prrv.2008.04.003","volume":"9","author":"JM Robertson","year":"2008","unstructured":"Robertson JM, Friedman EM, Rubin BK. Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev. 2008;9:213\u20139.","journal-title":"Paediatr Respir Rev"},{"key":"250_CR7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4193\/Rhino10.225","volume":"49","author":"MN Feuillet-Fieux","year":"2011","unstructured":"Feuillet-Fieux MN, Lenoir G, Sermet I, Elie C, Djadi-Prat J, Ferrec M, et al. Nasal polyposis and cystic fibrosis(CF): review of the literature. Rhinology. 2011;49:347\u201355.","journal-title":"Rhinology"},{"key":"250_CR8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archotol.1996.01890230055011","volume":"122","author":"TT Kingdom","year":"1996","unstructured":"Kingdom TT, Lee KC, FitzSimmons SC, Cropp GJ. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery. Arch Otolaryngol Head Neck Surg. 1996;122:1209\u201313.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"250_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1378\/chest.121.1.40","volume":"121","author":"G Henriksson","year":"2002","unstructured":"Henriksson G, Westrin KM, Karpati F, Wikstrom AC, Stierna P, Hjelte L. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest. 2002;121:40\u20137.","journal-title":"Chest"},{"key":"250_CR10","first-page":"194","volume":"34","author":"I Gaudemar De","year":"1996","unstructured":"De Gaudemar I, Contencin P, Van den Abbeele T, Munck A, Navarro J, Narcy P. Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection? Rhinology. 1996;34:194\u20137.","journal-title":"Rhinology"},{"key":"250_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2273.2003.00677.x","volume":"28","author":"M Cimmino","year":"2003","unstructured":"Cimmino M, Cavaliere M, Nardone M, Plantulli A, Orefice A, Esposito V, et al. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis. Clin Otolaryngol Allied Sci. 2003;28:125\u201332.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"250_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2273.2000.00241.x","volume":"25","author":"PJ Hadfield","year":"2000","unstructured":"Hadfield PJ, Rowe-Jones JM, Mackay IS. The prevalence of nasal polyps in adults with cystic fibrosis. Clin Otolaryngol Allied Sci. 2000;25:19\u201322.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"250_CR13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1398-9995.2005.00830.x","volume":"60","author":"W Fokkens","year":"2005","unstructured":"Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005;60:583\u2013601.","journal-title":"Allergy"},{"key":"250_CR14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/1099-0496(200012)30:6<481::AID-PPUL8>3.0.CO;2-N","volume":"30","author":"C Gysin","year":"2000","unstructured":"Gysin C, Alothman GA, Papsin BC. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol. 2000;30:481\u20139.","journal-title":"Pediatr Pulmonol"},{"key":"250_CR15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1017\/S0022215100109983","volume":"103","author":"AB Drake-Lee","year":"1989","unstructured":"Drake-Lee AB, Morgan DW. Nasal polyps and sinusitis in children with cystic fibrosis. J Laryngol Otol. 1989;103:753\u20135.","journal-title":"J Laryngol Otol"},{"key":"250_CR16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijporl.2008.01.010","volume":"72","author":"D Babinski","year":"2008","unstructured":"Babinski D, Trawinska-Bartnicka M. Rhinosinusitis in cystic fibrosis: not a simple story. Int J Pediatr Otorhinolaryngol. 2008;72:619\u201324.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"250_CR17","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1164\/ajrccm.159.5.9712056","volume":"159","author":"MB Jorissen","year":"1999","unstructured":"Jorissen MB, De Boeck K, Cuppens H. Genotype-phenotype correlations for the paranasal sinuses in cystic fibrosis. Am J Respir Crit Care Med. 1999;159:1412\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"250_CR18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/TCRM.S2379","volume":"4","author":"JR Newton","year":"2008","unstructured":"Newton JR, Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag. 2008;4:507\u201312.","journal-title":"Ther Clin Risk Manag"},{"key":"250_CR19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/thx.47.6.426","volume":"47","author":"RF Taylor","year":"1992","unstructured":"Taylor RF, Morgan DW, Nicholson PS, Mackay IS, Hodson ME, Pitt TL. Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis. Thorax. 1992;47:426\u20138.","journal-title":"Thorax"},{"key":"250_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/thx.2008.104711","volume":"64","author":"JG Mainz","year":"2009","unstructured":"\u2022\u2022 Mainz JG, Naehrlich L, Schien M, Kading M, Schiller I, Mayr S, et al. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax. 2009;64:535\u201340. This study provided proof of the cross-relation of upper and lower airways (\u201cone airway hypothesis\u201d) by genotypically identical P. aeruginosa clones in CF upper and lower airways. It also identified NL as the most sensitive method to sample the upper airways.","journal-title":"Thorax"},{"key":"250_CR21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","volume":"361","author":"F Ratjen","year":"2003","unstructured":"Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361:681\u20139.","journal-title":"Lancet"},{"key":"250_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcf.2011.01.003","volume":"10","author":"SP Schraven","year":"2011","unstructured":"\u2022\u2022 Schraven SP, Wehrmann M, Wagner W, Blumenstock G, Koitschev A. Prevalence and histopathology of chronic polypoid sinusitis in pediatric patients with cystic fibrosis. J Cyst Fibros. 2011;10:181\u20136. This article provided a histologic comparison of CF to non-CF NP, identifying abundant mucus glands in CF-NP with mucus retention.","journal-title":"J Cyst Fibros"},{"key":"250_CR23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00405-007-0393-y","volume":"264","author":"S Knipping","year":"2007","unstructured":"Knipping S, Holzhausen HJ, Riederer A, Bloching M. Cystic fibrosis: ultrastructural changes of nasal mucosa. Eur Arch Otorhinolaryngol. 2007;264:1413\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"250_CR24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1569-1993(02)00072-3","volume":"1","author":"C Bergoin","year":"2002","unstructured":"Bergoin C, Gosset P, Lamblin C, Bolard F, Turck D, Tonnel AB, et al. Cell and cytokine profile in nasal secretions in cystic fibrosis. J Cyst Fibros. 2002;1:110\u20135.","journal-title":"J Cyst Fibros"},{"key":"250_CR25","first-page":"155","volume":"36","author":"D Beju","year":"2004","unstructured":"Beju D, Meek WD, Kramer JC. The ultrastructure of the nasal polyps in patients with and without cystic fibrosis. J Submicrosc Cytol Pathol. 2004;36:155\u201365.","journal-title":"J Submicrosc Cytol Pathol"},{"key":"250_CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/path.1711660412","volume":"166","author":"WR Henderson Jr","year":"1992","unstructured":"Henderson Jr WR, Chi EY. Degranulation of cystic fibrosis nasal polyp mast cells. J Pathol. 1992;166:395\u2013404.","journal-title":"J Pathol"},{"key":"250_CR27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2273.1997.00003.x","volume":"22","author":"JM Rowe-Jones","year":"1997","unstructured":"Rowe-Jones JM, Shembekar M, Trendell-Smith N, Mackay IS. Polypoidal rhinosinusitis in cystic fibrosis: a clinical and histopathological study. Clin Otolaryngol Allied Sci. 1997;22:167\u201371.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"250_CR28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.2005.02215.x","volume":"35","author":"S Claeys","year":"2005","unstructured":"Claeys S, Van Hoecke H, Holtappels G, Gevaert P, De Belder T, Verhasselt B, et al. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy. 2005;35:467\u201372.","journal-title":"Clin Exp Allergy"},{"key":"250_CR29","unstructured":"Derycke L, Zhang N, Holtappels G, Dutre T, Bachert C. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis. J Cyst Fibros. 2011. doi: 10.1016\/j\/jcf.2011.11.007"},{"key":"250_CR30","first-page":"355","volume":"128","author":"GS Rachelefsky","year":"1974","unstructured":"Rachelefsky GS, Osher A, Dooley RE, Ank B, Stiehm ER. Coexistent respiratory allergy and cystic fibrosis. Am J Dis Child. 1974;128:355\u20139.","journal-title":"Am J Dis Child"},{"issue":"Pt 3","key":"250_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/000456329102800311","volume":"28","author":"J Biewenga","year":"1991","unstructured":"Biewenga J, Stoop AE, Baker HE, Swart SJ, Nauta JJ, van Kamp GJ, et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem. 1991;28(Pt 3):260\u20136.","journal-title":"Ann Clin Biochem"},{"key":"250_CR32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/infdis\/175.3.638","volume":"175","author":"TL Noah","year":"1997","unstructured":"Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis. 1997;175:638\u201347.","journal-title":"J Infect Dis"},{"key":"250_CR33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/00016489609137875","volume":"116","author":"D Wang","year":"1996","unstructured":"Wang D, Brihaye P, Smitz J, De Waele M, Clement P. Inflammatory cells and mediator concentrations in nasal secretions of patients with cystic fibrosis. Acta Otolaryngol. 1996;116:472\u20136.","journal-title":"Acta Otolaryngol"},{"key":"250_CR34","first-page":"395","volume":"15","author":"E Lesprit","year":"2000","unstructured":"Lesprit E, Escudier E, Roger G, Pruliere V, Lenoir G, Reinert P, et al. Characterization of inflammatory reaction in upper airways of cystic fibrosis patients. Histol Histopathol. 2000;15:395\u2013402.","journal-title":"Histol Histopathol"},{"key":"250_CR35","first-page":"1075","volume":"151","author":"TZ Khan","year":"1995","unstructured":"Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151:1075\u201382.","journal-title":"Am J Respir Crit Care Med"},{"key":"250_CR36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1128\/CDLI.6.2.260-265.1999","volume":"6","author":"JM Wolter","year":"1999","unstructured":"Wolter JM, Rodwell RL, Bowler SD, McCormack JG. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. Clin Diagn Lab Immunol. 1999;6:260\u20135.","journal-title":"Clin Diagn Lab Immunol"},{"key":"250_CR37","first-page":"183","volume":"31","author":"VJ Lund","year":"1993","unstructured":"Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31:183\u20134.","journal-title":"Rhinology"},{"key":"250_CR38","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","volume":"117","author":"VJ Lund","year":"1997","unstructured":"Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117:S35\u201340.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"250_CR39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0194-5998(95)70152-4","volume":"113","author":"RE Gliklich","year":"1995","unstructured":"Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104\u20139.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"250_CR40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/028418501127346639","volume":"42","author":"HB Eggesbo","year":"2001","unstructured":"Eggesbo HB, Dolvik S, Stiris M, Sovik S, Storrosten OT, Kolmannskog F. Complementary role of MR imaging of ethmomaxillary sinus disease depicted at CT in cystic fibrosis. Acta Radiol. 2001;42:144\u201350.","journal-title":"Acta Radiol"},{"issue":"Suppl 1","key":"250_CR41","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1569-1993(09)60005-9","volume":"8","author":"JG Mainz","year":"2009","unstructured":"Mainz JG, Koitschev A. Management of chronic rhinosinusitis in CF. J Cyst Fibros. 2009;8 Suppl 1:S10\u20134.","journal-title":"J Cyst Fibros: Official journal of the European Cystic Fibrosis Society"},{"key":"250_CR42","doi-asserted-by":"crossref","unstructured":"Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database Syst Rev. 2011;CD005232.","DOI":"10.1002\/14651858.CD005232.pub3"},{"key":"250_CR43","doi-asserted-by":"crossref","unstructured":"Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;CD006394.","DOI":"10.1002\/14651858.CD006394"},{"key":"250_CR44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00005537-199704000-00013","volume":"107","author":"AR Talbot","year":"1997","unstructured":"Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope. 1997;107:500\u20133.","journal-title":"Laryngoscope"},{"key":"250_CR45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s004050000271","volume":"257","author":"G Bachmann","year":"2000","unstructured":"Bachmann G, Hommel G, Michel O. Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol. 2000;257:537\u201341.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"250_CR46","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1097\/01.mlg.0000149463.95950.c5","volume":"114","author":"PJ Wormald","year":"2004","unstructured":"Wormald PJ, Cain T, Oates L, Hawke L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004;114:2224\u20137.","journal-title":"Laryngoscope"},{"key":"250_CR47","first-page":"213","volume":"46","author":"W Moller","year":"2008","unstructured":"Moller W, Schuschnig U, Meyer G, Mentzel H, Keller M. Ventilation and drug delivery to the paranasal sinuses: studies in a nasal cast using pulsating airflow. Rhinology. 2008;46:213\u201320.","journal-title":"Rhinology"},{"key":"250_CR48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.otohns.2009.12.028","volume":"142","author":"W Moller","year":"2010","unstructured":"\u2022\u2022 Moller W, Schuschnig U, Khadem Saba G, Meyer G, Junge-Hulsing B, Keller M, et al. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers. Otolaryngol Head Neck Surg. 2010;142:382\u20138. This study provided proof of deposition of vibrating aerosols into paranasal sinuses in vivo by scintigraphy, which is not achieved in nasal inhalation without pulsation or by nasal sprays or drops.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"250_CR49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.anl.2010.09.001","volume":"38","author":"JG Mainz","year":"2011","unstructured":"\u2022\u2022 Mainz JG, Schiller I, Ritschel C, Mentzel HJ, Riethmuller J, Koitschev A, et al. Sinonasal inhalation of dornase alfa in CF: a double-blind placebo-controlled cross-over pilot trial. Auris Nasus Larynx. 2011;38:220\u20137. This was the first study to assess sinonasal inhalation with vibrating aerosols in CRS patients with significantly positive results in SNOT-20 already in the pilot trial.","journal-title":"Auris, Nasus, Larynx"},{"key":"250_CR50","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0140-6736(93)92422-P","volume":"341","author":"C Koch","year":"1993","unstructured":"Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet. 1993;341:1065\u20139.","journal-title":"Lancet"},{"key":"250_CR51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/thx.51.2.119","volume":"51","author":"PL Shah","year":"1996","unstructured":"Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax. 1996;51:119\u201325.","journal-title":"Thorax"},{"key":"250_CR52","doi-asserted-by":"crossref","unstructured":"Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2010;CD001127.","DOI":"10.1002\/14651858.CD001127.pub2"},{"key":"250_CR53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archotol.126.5.581","volume":"126","author":"EM Raynor","year":"2000","unstructured":"Raynor EM, Butler A, Guill M, Bent 3rd JP. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2000;126:581\u20133.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"250_CR54","doi-asserted-by":"crossref","unstructured":"Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch Otolaryngol Head Neck Surg. 2005;131(12):1097\u2013101.","DOI":"10.1001\/archotol.131.12.1097"},{"key":"250_CR55","doi-asserted-by":"crossref","unstructured":"\u2022 Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2009;CD001506. This article discusses the significant effects of bronchial inhalation of hypertonic saline in CF.","DOI":"10.1002\/14651858.CD001506.pub3"},{"key":"250_CR56","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1183\/09031936.04.00014404","volume":"24","author":"PR Burgel","year":"2004","unstructured":"Burgel PR, Cardell LO, Ueki IF, Nadel JA. Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps. Eur Respir J. 2004;24:594\u2013600.","journal-title":"Eur Respir J"},{"key":"250_CR57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archotol.124.5.513","volume":"124","author":"VJ Lund","year":"1998","unstructured":"Lund VJ, Flood J, Sykes AP, Richards DH. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg. 1998;124:513\u20138.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"250_CR58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3132\/pcrj.2008.00029","volume":"17","author":"M Thomas","year":"2008","unstructured":"Thomas M, Yawn BP, Price D, Lund V, Mullol J, Fokkens W. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007 - a summary. Prim Care Respir J. 2008;17:79\u201389.","journal-title":"Prim Care Respir J"},{"key":"250_CR59","first-page":"43","volume":"17","author":"JD Donaldson","year":"1988","unstructured":"Donaldson JD, Gillespie CT. Observations on the efficacy of intranasal beclomethasone dipropionate in cystic fibrosis patients. J Otolaryngol. 1988;17:43\u20135.","journal-title":"J Otolaryngol"},{"key":"250_CR60","first-page":"220","volume":"36","author":"D Costantini","year":"1990","unstructured":"Costantini D, Di Cicco M, Giunta A, Amabile G. Nasal polyposis in cystic fibrosis treated by beclomethasone dipropionate. Acta Univ Carol Med. 1990;36:220\u20131.","journal-title":"Acta Univ Carol Med"},{"key":"250_CR61","doi-asserted-by":"crossref","unstructured":"\u2022 Beer H, Southern KW, Swift AC. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. Cochrane Database Syst Rev. 2011;CD008253. This is a review on TS therapy in CF-NP.","DOI":"10.1002\/14651858.CD008253.pub2"},{"key":"250_CR62","first-page":"1067","volume":"136","author":"RC Stern","year":"1982","unstructured":"Stern RC, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child. 1982;136:1067\u201370.","journal-title":"Am J Dis Child"},{"key":"250_CR63","first-page":"63","volume":"38","author":"PJ Hadfield","year":"2000","unstructured":"Hadfield PJ, Rowe-Jones JM, Mackay IS. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology. 2000;38:63\u20135.","journal-title":"Rhinology"},{"key":"250_CR64","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1288\/00005537-199504000-00002","volume":"105","author":"TM Davidson","year":"1995","unstructured":"Davidson TM, Murphy C, Mitchell M, Smith C, Light M. Management of chronic sinusitis in cystic fibrosis. Laryngoscope. 1995;105:354\u20138.","journal-title":"Laryngoscope"},{"key":"250_CR65","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archotol.1995.01890050058011","volume":"121","author":"RB Moss","year":"1995","unstructured":"Moss RB, King VV. Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg. 1995;121:566\u201372.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"250_CR66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S0022215100143907","volume":"113","author":"SM Graham","year":"1999","unstructured":"Graham SM, Launspach JL, Welsh MJ, Zabner J. Sequential magnetic resonance imaging analysis of the maxillary sinuses: implications for a model of gene therapy in cystic fibrosis. J Laryngol Otol. 1999;113:329\u201335.","journal-title":"J Laryngol Otol"},{"key":"250_CR67","doi-asserted-by":"crossref","unstructured":"\u2022 Ryan G, Singh M, Dwan K. Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev. 2011;CD001021. This article provides proof of the therapeutic effect and safety of bronchial antibiotic inhalation in CF lung disease.","DOI":"10.1002\/14651858.CD001021.pub2"},{"key":"250_CR68","doi-asserted-by":"crossref","unstructured":"Mainz JG, Schien C, Sch\u00e4dlich K, Pfister W, Schelhorn-Neise P, Koitschev A, et al. Sinonasal inhalation of Tobramycin in CF-patients with P. aeruginosa-colonization of the upper airways - results of a multicentric placebo controlled pilot study - Oral and poster: 34rd European Cystic Fibrosis Conference, 06.2011, Hamburg. J Cyst Fibros. 2011;10S:21.","DOI":"10.1016\/S1569-1993(11)60101-X"},{"key":"250_CR69","doi-asserted-by":"crossref","unstructured":"Mainz JG, Michl R, Pfister W, Beck JF. Cystic Fibrosis Upper Airways Primary Colonization with P. aeruginosa: Eradicated by Sinonasal Antibiotic Inhalation. Am J Respir Crit Care Med. 2011;184(9):1089\u201390.","DOI":"10.1164\/ajrccm.184.9.1089"},{"key":"250_CR70","doi-asserted-by":"crossref","unstructured":"Mainz JG, Hentschel J, Schien C, Cramer N, Pfister W, Beck JF, T\u00fcmmler B. P. aeruginosa persists in the upper airways after lung transplantation. J Cyst Fibros. 2011. doi: 10.1016\/j.jcf.2011.10.009 .","DOI":"10.1016\/j.jcf.2011.10.009"},{"key":"250_CR71","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","volume":"351","author":"A Jaffe","year":"1998","unstructured":"Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet. 1998;351:420.","journal-title":"Lancet"},{"issue":"Suppl 9A","key":"250_CR72","first-page":"5S","volume":"117","author":"J Tamaoki","year":"2004","unstructured":"Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med. 2004;117(Suppl 9A):5S\u201311S.","journal-title":"Am J Med"},{"key":"250_CR73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2500\/105065899782102791","volume":"13","author":"M Nonaka","year":"1999","unstructured":"Nonaka M, Pawankar R, Tomiyama S, Yagi T. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol. 1999;13:267\u201372.","journal-title":"Am J Rhinol"},{"key":"250_CR74","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/00005537-199712000-00016","volume":"107","author":"H Suzuki","year":"1997","unstructured":"Suzuki H, Shimomura A, Ikeda K, Furukawa M, Oshima T, Takasaka T. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope. 1997;107:1661\u20136.","journal-title":"Laryngoscope"},{"key":"250_CR75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2500\/105065800782102717","volume":"14","author":"T Yamada","year":"2000","unstructured":"Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol. 2000;14:143\u20138.","journal-title":"Am J Rhinol"},{"key":"250_CR76","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1398-9995.2011.02693.x","volume":"66","author":"WJ Videler","year":"2011","unstructured":"Videler WJ, Badia L, Harvey RJ, Gane S, Georgalas C, van der Meulen FW, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66:1457\u201368.","journal-title":"Allergy"},{"key":"250_CR77","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","volume":"332","author":"MW Konstan","year":"1995","unstructured":"Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995;332:848\u201354.","journal-title":"N Engl J Med"},{"key":"250_CR78","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2310\/7070.2007.0049","volume":"36","author":"DR Lindstrom","year":"2007","unstructured":"Lindstrom DR, Conley SF, Splaingard ML, Gershan WM. Ibuprofen therapy and nasal polyposis in cystic fibrosis patients. J Otolaryngol. 2007;36:309\u201314.","journal-title":"J Otolaryngol"},{"key":"250_CR79","unstructured":"Mainz JG, Schien M, Naehrlich L, K\u00e4ding M, Thoss K, Frey G, et al. Prevalence of CF-related chronic rhinosinusitis - results from a multicentre interdisciplinary study. In 33rd European Cystic Fibrosis Conference; 2010. J Cyst Fibros. 2010:9 S1, 118."},{"key":"250_CR80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.anl.2005.03.001","volume":"32","author":"RN Beata","year":"2005","unstructured":"Beata RN, Wojciech F, Stanislaw S, Ryszard M. The influence of anti-inflammatory drugs on the proliferation of fibroblast derived from nasal polyps. Auris Nasus Larynx. 2005;32:225\u20139.","journal-title":"Auris, Nasus, Larynx"},{"key":"250_CR81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0385-8146(00)00052-3","volume":"27","author":"F Saji","year":"2000","unstructured":"Saji F, Nonaka M, Pawankar R. Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts. Auris Nasus Larynx. 2000;27:247\u201352.","journal-title":"Auris, Nasus, Larynx"},{"key":"250_CR82","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2222.1998.00380.x","volume":"28","author":"DL Hamilos","year":"1998","unstructured":"Hamilos DL, Leung DY, Huston DP, Kamil A, Wood R, Hamid Q. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy. 1998;28:1145\u201352.","journal-title":"Clin Exp Allergy"},{"key":"250_CR83","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","volume":"128","author":"P Gevaert","year":"2011","unstructured":"Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128:989\u201395. e981\u2013988.","journal-title":"J Allergy Clin Immunol"},{"key":"250_CR84","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/00005537-199812000-00009","volume":"108","author":"DL Schulte","year":"1998","unstructured":"Schulte DL, Kasperbauer JL. Safety of paranasal sinus surgery in patients with cystic fibrosis. Laryngoscope. 1998;108:1813\u20135.","journal-title":"Laryngoscope"},{"key":"250_CR85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/014556139407300706","volume":"73","author":"W Messerklinger","year":"1994","unstructured":"Messerklinger W. Background and evolution of endoscopic sinus surgery. Ear Nose Throat J. 1994;73:449\u201350.","journal-title":"Ear Nose Throat J"},{"key":"250_CR86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MLG.0b013e31802d6e4f","volume":"117","author":"T Keck","year":"2007","unstructured":"Keck T, Rozsasi A. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope. 2007;117:475\u20139.","journal-title":"Laryngoscope"},{"key":"250_CR87","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/archoto.2010.162","volume":"136","author":"S Rickert","year":"2010","unstructured":"\u2022 Rickert S, Banuchi VE, Germana JD, Stewart MG, April MM. Cystic fibrosis and endoscopic sinus surgery: relationship between nasal polyposis and likelihood of revision endoscopic sinus surgery in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2010;136:988\u201392. This is an analysis of recurrences after CF-NP surgery.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"250_CR88","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00005537-199703000-00009","volume":"107","author":"D Madonna","year":"1997","unstructured":"Madonna D, Isaacson G, Rosenfeld RM, Panitch H. Effect of sinus surgery on pulmonary function in patients with cystic fibrosis. Laryngoscope. 1997;107:328\u201331.","journal-title":"Laryngoscope"},{"key":"250_CR89","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archoto.2011.68","volume":"137","author":"AJ Osborn","year":"2011","unstructured":"\u2022 Osborn AJ, Leung R, Ratjen F, James AL. Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2011;137:542\u20137. This article provides retrospective identification of lacking effects of sinonasal surgery in CF on pulmonary function, which requires further prospective investigation.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"250_CR90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2273.2002.00515.x","volume":"27","author":"R Kayarkar","year":"2002","unstructured":"Kayarkar R, Clifton NJ, Woolford TJ. An evaluation of the best head position for instillation of steroid nose drops. Clin Otolaryngol Allied Sci. 2002;27:18\u201321.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"250_CR91","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2500\/ajr.2006.20.2885","volume":"20","author":"U Raghavan","year":"2006","unstructured":"Raghavan U, Jones NS. A prospective randomized blinded cross-over trial using nasal drops in patients with nasal polyposis: an evaluation of effectiveness and comfort level of two head positions. Am J Rhinol. 2006;20:397\u2013400.","journal-title":"Am J Rhinol"},{"key":"250_CR92","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/00016480500388877","volume":"126","author":"L Johansson","year":"2006","unstructured":"Johansson L, Oberg D, Melen I, Bende M. Do topical nasal decongestants affect polyps? Acta Otolaryngol. 2006;126:288\u201390.","journal-title":"Acta Otolaryngol"},{"key":"250_CR93","first-page":"295","volume":"19","author":"PM Graf","year":"2007","unstructured":"Graf PM. Rhinitis medicamentosa. Clin Allergy Immunol. 2007;19:295\u2013304.","journal-title":"Clin Allergy Immunol"},{"key":"250_CR94","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1017\/S0022215106002167","volume":"120","author":"A Helbling","year":"2006","unstructured":"Helbling A, Baumann A, Hanni C, Caversaccio M. Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol. 2006;120:1023\u20135.","journal-title":"J Laryngol Otol"},{"key":"250_CR95","first-page":"530","volume":"27","author":"B Heintz","year":"1989","unstructured":"Heintz B, Schlenter WW, Kirsten R, Nelson K. Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis\u2013a multi-centric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol. 1989;27:530\u20134.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"250_CR96","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archotol.1992.01880050057013","volume":"118","author":"JP Cuyler","year":"1992","unstructured":"Cuyler JP. Follow-up of endoscopic sinus surgery on children with cystic fibrosis. Arch Otolaryngology Head Neck Surg. 1992;118:505\u20136.","journal-title":"Arch Otolaryngology Head Neck Surg"},{"key":"250_CR97","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0194-5998(95)70082-X","volume":"113","author":"GJ Nishioka","year":"1995","unstructured":"Nishioka GJ, Barbero GJ, Konig P, Parsons DS, Cook PR, Davis WE. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol Head Neck Surg. 1995;113:440\u20135.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"250_CR98","first-page":"99","volume":"114","author":"A Coste","year":"1997","unstructured":"Coste A, Idrissi F, Beautru R, Lenoir G, Reinert P, Manach Y, et al. Endoscopic endonasal ethmoidectomy in severe sinusitis of cystic fibrosis. Mid-term results in 12 patients. Ann Otolaryngol Chir Cervicofac. 1997;114(4):99\u2013104.","journal-title":"Annales d\u2019oto-laryngologie et de chirurgie cervico faciale: bulletin de la Societe d\u2019oto-laryngologie des hopitaux de Paris"},{"key":"250_CR99","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00005537-199707000-00025","volume":"107","author":"JM Triglia","year":"1997","unstructured":"Triglia JM, Nicollas R. Nasal and sinus polyposis in children. Laryngoscope. 1997;107:963\u20136.","journal-title":"Laryngoscope"},{"key":"250_CR100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/000348940211101204","volume":"111","author":"MW Yung","year":"2002","unstructured":"Yung MW, Gould J, Upton GJ. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol. 2002;111:1081\u20136.","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-012-0250-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0250-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T19:13:21Z","timestamp":1686770001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-012-0250-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,17]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1007\/s11882-012-0250-y","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,17]]}}}